Zhu Jin Selected Research

Zhu Jin Research Topics

Disease

17	Neoplasms (Cancer) 02/2024 - 01/2013
4	Biliary Atresia 12/2022 - 01/2017
3	Hypoxia (Hypoxemia) 02/2024 - 05/2010
3	Inflammation (Inflammations) 12/2022 - 03/2014
3	Pre-Eclampsia (Preeclampsia) 01/2016 - 12/2012
2	Type 2 Diabetes Mellitus (MODY) 09/2023 - 05/2014
2	Infections 01/2022 - 03/2014
2	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 01/2021 - 01/2018
2	Dyspnea (Shortness of Breath) 11/2020 - 11/2018
2	Adenocarcinoma 01/2018 - 03/2012
2	Choledochal Cyst (Choledochal Cysts) 01/2018 - 01/2017
2	Fibrosis (Cirrhosis) 01/2017 - 01/2015
2	Gastritis 10/2014 - 08/2010
2	Carcinogenesis 03/2012 - 10/2003
2	Aberrant Crypt Foci 04/2009 - 10/2003
1	Granuloma 03/2024
1	Atherosclerosis 03/2024
1	Gastrointestinal Neoplasms (Gastrointestinal Cancer) 03/2024
1	Pathologic Constriction (Stenosis) 02/2024
1	Anastomotic Leak 02/2024
1	Brain Injuries (Brain Injury) 02/2024
1	Urinary Incontinence 01/2024
1	Peripheral Nervous System Diseases (PNS Diseases) 09/2023
1	Tuberculosis (Tuberculoses) 03/2023
1	Avian Reticuloendotheliosis 03/2023
1	Abscess 01/2023
1	Neoplasm Metastasis (Metastasis) 01/2023
1	Triple Negative Breast Neoplasms 01/2023
1	Cholangitis 12/2022
1	Colorectal Neoplasms (Colorectal Cancer) 12/2022
1	Jaundice (Icterus) 12/2022
1	Intestinal Atresia 06/2022
1	Cholangiocarcinoma 09/2021
1	Interstitial Cystitis (Interstitial Cystitis, Chronic) 05/2021
1	COVID-19 11/2020
1	Disease Progression 11/2020
1	Fever (Fevers) 11/2020

Drug/Important Bio-Agent (IBA)

5	AutoantibodiesIBA 01/2016 - 12/2012
4	EnzymesIBA 02/2024 - 05/2010
4	Proteins (Proteins, Gene)FDA Link 02/2024 - 04/2005
3	Angiotensin IIIBA 10/2015 - 12/2011
3	Sulindac (Copal)FDA LinkGeneric 04/2009 - 10/2003
2	LipidsIBA 03/2024 - 01/2016
2	Reactive Oxygen Species (Oxygen Radicals)IBA 02/2024 - 01/2023
2	MicellesIBA 02/2024 - 01/2021
2	Interleukin-6 (Interleukin 6)IBA 03/2023 - 12/2022
2	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2022 - 12/2012
2	MicroRNAs (MicroRNA)IBA 01/2021 - 01/2018
2	Antineoplastic Agents (Antineoplastics)IBA 11/2018 - 01/2018
2	DNA (Deoxyribonucleic Acid)IBA 01/2018 - 03/2007
2	Messenger RNA (mRNA)IBA 01/2018 - 01/2015
2	CollagenIBA 01/2017 - 08/2010
2	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2017 - 01/2016
2	Angiotensin Receptors (Angiotensin II Receptor)IBA 01/2016 - 01/2013
2	Small Interfering RNA (siRNA)IBA 09/2015 - 03/2012
2	Indicators and Reagents (Reagents)IBA 03/2014 - 03/2007
2	PPAR gammaIBA 04/2009 - 10/2003
2	Peroxisome ProliferatorsIBA 04/2009 - 10/2003
1	cholesterol 25-hydroxylaseIBA 03/2024
1	Phosphopyruvate Hydratase (Enolase)IBA 02/2024
1	salicylhydroxamic acid (SHAM)IBA 01/2024
1	NAD (NADH)IBA 09/2023
1	Transcription Factor AP-1 (Transcription Factor AP 1)IBA 03/2023
1	Mitogen-Activated Protein Kinase 8IBA 03/2023
1	Proto-Oncogene Proteins c-akt (Protein Kinase B)IBA 03/2023
1	Retinoid X Receptor alphaIBA 03/2023
1	Transcription Factors (Transcription Factor)IBA 03/2023
1	Estrogen Receptor alphaIBA 03/2023
1	kushenIBA 03/2023
1	Basic Helix-Loop-Helix Transcription FactorsIBA 03/2023
1	Cytotoxins (Cytolysins)IBA 01/2023
1	tocophersolanIBA 01/2023
1	Tocopherols (Tocopherol)IBA 01/2023
1	polyethylene glycol 1000IBA 01/2023
1	Succinic Acid (Succinate)IBA 01/2023
1	1- (2,4- dichlorobenzyl)indazole- 3- carbohydrazide (adjudin)IBA 01/2023
1	Doxorubicin (Adriamycin)FDA LinkGeneric 01/2023
1	BilirubinIBA 12/2022
1	Interleukin-33IBA 12/2022
1	Interleukin-8 (Interleukin 8)IBA 12/2022
1	HypoxanthineIBA 10/2022
1	Glutamic Acid (Glutamate)FDA Link 10/2022
1	Butyrates (Butyrate)IBA 10/2022
1	Glutamine (L-Glutamine)FDA Link 10/2022
1	Paclitaxel (Taxol)FDA LinkGeneric 09/2021
1	poly(lactide) (polylactic acid)IBA 09/2021
1	Ofloxacin (Ofloxacine)FDA LinkGeneric 09/2021
1	Mitogen-Activated Protein Kinase 3IBA 05/2021
1	Circular RNAIBA 01/2021
1	Nucleic AcidsIBA 11/2020
1	Adrenal Cortex Hormones (Corticosteroids)IBA 11/2020

Therapy/Procedure

10	Therapeutics 02/2024 - 08/2010
4	Stents 12/2022 - 01/2018
3	Drug Therapy (Chemotherapy) 02/2024 - 09/2015
2	Electroacupuncture 03/2024 - 05/2021
1	Immunotherapy 02/2024
1	Patient Readmission 02/2024
1	Aftercare (After-Treatment) 01/2024
1	Splenectomy 01/2023
1	Conservative Treatment 01/2023